In search of new biomarkers for nonalcoholic fatty liver disease

scientific article published on 26 July 2016

In search of new biomarkers for nonalcoholic fatty liver disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/CLD.563
P932PMC publication ID6490188
P698PubMed publication ID31041057

P2093author name stringVincent Wai-Sun Wong
Ting-Ting Chan
P2860cites workThe diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological AssociationQ29617157
Magnetic resonance elastography is superior to acoustic radiation force impulse for the Diagnosis of fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease: A prospective study.Q30364476
Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver diseaseQ30389327
The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study.Q35615790
Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver DiseaseQ35893923
Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver diseaseQ37850396
Systematic review with meta-analysis: non-invasive assessment of non-alcoholic fatty liver disease--the role of transient elastography and plasma cytokeratin-18 fragmentsQ38168939
The dual and opposite role of the TM6SF2-rs58542926 variant in protecting against cardiovascular disease and conferring risk for nonalcoholic fatty liver: A meta-analysisQ38578940
Non-invasive diagnosis of non-alcoholic steatohepatitis by combined serum biomarkersQ83400241
Liver stiffness measurement using XL probe in patients with nonalcoholic fatty liver diseaseQ87406034
P433issue1
P921main subjectmetabolic dysfunction–associated steatotic liver diseaseQ1546498
fatty liver diseaseQ6058862
biomarkerQ864574
liver diseaseQ929737
P304page(s)19-23
P577publication date2016-07-26
P1433published inClinical liver diseaseQ27726171
P1476titleIn search of new biomarkers for nonalcoholic fatty liver disease
P478volume8

Reverse relations

cites work (P2860)
Q90708951Glutamine Breakdown as a Potential Metabolic Biomarker for Nonalcoholic Steatohepatitis
Q91621810Three-dimensional spatially resolved geometrical and functional models of human liver tissue reveal new aspects of NAFLD progression

Search more.